TRAW vs WDAY · rev $2.8M vs P/E 135, rev $5.19B
Traws Pharma Inc (TRAW) versus Workday Inc (WDAY) — a side-by-side from cached financials, not a winner call.
Traws Pharma Inc (TRAW) is a biotechnology company listed on NASDAQ.
Workday Inc (WDAY) is a software - application company listed on US.
Latest reported TRAW revenue for 2025-09-30 was $2.8M. Net income was $16.6M. Revenue was up 2.1% from 2025-06-30 to 2025-09-30. TRAW currently screens at market cap $12.1M.
Latest reported WDAY revenue for 2026-07-31 was $5.19B. Net income was $854.0M. WDAY currently screens at market cap $64.45B and trailing P/E 135.1.
TRAW currently screens at market cap $12.1M. WDAY currently screens at market cap $64.45B and trailing P/E 135.1.
Not investment advice. Open the TRAW and WDAY stock pages for the full models.
Not investment advice.